Substance use patterns of HVTN phase I clinical trial participants: Enrollment, Risk Reduction Counseling and Retention

BACKGROUND: The primary objectives of HIV Vaccine Trials Network (HVTN) phase 1 preventive HIV vaccine clinical trials are to assess safety and immune response to study products. Participant alcohol and drug use may affect adherence, retention, and risk of HIV infection. Data on the effects of subst...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine
Main Authors: Andrasik, Michele Peake, Thiam-Diouf, Arame, Metch, Barbara, Sharpe, Cameron, Mulugeta, Robel
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828683/
https://ncbi.nlm.nih.gov/pubmed/29395528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.11.032
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items